Clinical applications of proteomic techniques

Sabia D, Villegas Portero R
Record ID 32007000459
English, Spanish
Authors' objectives: 1. To describe the views of experts in the field of proteomics regarding techniques which are already being applied in clinical practice, or which may see the light in the near future. 2. To identify applied research publications on proteomic techniques. 3. To describe those publications in terms of type of proteomic tests, diseases they are applied to or are proposed for, and clinical usefulness.
Authors' recommendations: 1. No standardised use of proteomic techniques have been identified in current clinical practice for the management of any disease. 2. There is no consensus among experts regarding the possible introduction of proteomics into clinical practice over the short-tomedium term. Opinions are divided: 44% believe that this is highly improbable or speculative and 56% claim that some sort of application is in the making. In this latter case, none of the respondents pinpointed specific applications or diseases. 3. Should proteomics be implemented in clinical practice in the near future, mass spectrometry, especially SELDI-TOF, is the most plausible technique ; on the basis of experts- responses and the bibliometric study ;while oncology and pharmacoproteomics are the most likely fields of application.
Authors' methods: Systematic review
Details
Project Status: Completed
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Proteomics
Contact
Organisation Name: Andalusian Health Technology Assessment Area
Contact Address: Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. InnovaciĆ³n, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name: aetsa.csalud@juntadeandalucia.es
Contact Email: aetsa.csalud@juntadeandalucia.es
Copyright: Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.